Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Dova Pharmaceuticals, Inc. (DOVA)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-18 | Dec-31-17 |
| | 10-K | 10-K |
| Revenues | 100.0% | |
| Cost of goods sold | 10.2% | |
| Gross profit | 89.8% | |
| Selling, general and administrative | 536.8% | |
| Research and development | 158.7% | |
| Depreciation | 0.3% | |
| EBIT | -616.0% | |
| Pre-tax income | -626.6% | |
| Income taxes | 0.0% | |
| Net income | -626.6% | |
|